Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Schuster

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Mabs|June 6, 2012
Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314Ralf Kircheis, Nicole Halanek, Iris Koller, et al.
Wilderness & Environmental Medicine|March 24, 2012
Recombinant angiotensin-converting enzyme 2 suppresses pulmonary vasoconstriction in acute hypoxiaAxel Kleinsasser, Iris Pircher, Benedict Treml, et al.
International Journal of Hypertension|April 21, 2012
Recombinant Expression and Characterization of Human and Murine ACE2: Species-Specific Activation of the Alternative Renin-Angiotensin-SystemMarko Poglitsch, Oliver Domenig, Cornelia Schwager, et al.
Hypertension (Dallas, Tex. : 1979)|July 11, 2012
Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2Minghao Ye, Jan Wysocki, Francisco R Gonzalez-Pacheco, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 12, 2006
Inhibition of xenograft tumor growth and down-regulation of ErbB receptors by an antibody directed against Lewis Y antigenHesso Farhan, Christian Schuster, Markus Klinger, et al.
Biotechnology Journal|April 13, 2007
In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression systemManfred Schuster, Wolfgang Jost, Geert C Mudde, et al.
Critical Care Medicine|October 24, 2009
Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in pigletsBenedikt Treml, Nikolaus Neu, Axel Kleinsasser, et al.
Cancer Research|September 6, 2005
Improved effector functions of a therapeutic monoclonal Lewis Y-specific antibody by glycoform engineeringManfred Schuster, Pablo Umana, Claudia Ferrara, et al.
Mabs|August 26, 2016
Charge heterogeneity: Basic antibody charge variants with increased binding to Fc receptorsBeate Hintersteiner, Nico Lingg, Peiqing Zhang, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2010
Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2JiuChang Zhong, Danny Guo, Christopher B Chen, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Mabs|June 6, 2012
Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314Ralf Kircheis, Nicole Halanek, Iris Koller, et al.
Wilderness & Environmental Medicine|March 24, 2012
Recombinant angiotensin-converting enzyme 2 suppresses pulmonary vasoconstriction in acute hypoxiaAxel Kleinsasser, Iris Pircher, Benedict Treml, et al.
International Journal of Hypertension|April 21, 2012
Recombinant Expression and Characterization of Human and Murine ACE2: Species-Specific Activation of the Alternative Renin-Angiotensin-SystemMarko Poglitsch, Oliver Domenig, Cornelia Schwager, et al.
Hypertension (Dallas, Tex. : 1979)|July 11, 2012
Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2Minghao Ye, Jan Wysocki, Francisco R Gonzalez-Pacheco, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 12, 2006
Inhibition of xenograft tumor growth and down-regulation of ErbB receptors by an antibody directed against Lewis Y antigenHesso Farhan, Christian Schuster, Markus Klinger, et al.
Biotechnology Journal|April 13, 2007
In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression systemManfred Schuster, Wolfgang Jost, Geert C Mudde, et al.
Critical Care Medicine|October 24, 2009
Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in pigletsBenedikt Treml, Nikolaus Neu, Axel Kleinsasser, et al.
Cancer Research|September 6, 2005
Improved effector functions of a therapeutic monoclonal Lewis Y-specific antibody by glycoform engineeringManfred Schuster, Pablo Umana, Claudia Ferrara, et al.
Mabs|August 26, 2016
Charge heterogeneity: Basic antibody charge variants with increased binding to Fc receptorsBeate Hintersteiner, Nico Lingg, Peiqing Zhang, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2010
Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2JiuChang Zhong, Danny Guo, Christopher B Chen, et al.
Pageof 3